1. Home
  2. AVAV vs GH Comparison

AVAV vs GH Comparison

Compare AVAV & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

N/A

Current Price

$213.79

Market Cap

11.3B

Sector

Industrials

ML Signal

N/A

Logo Guardant Health Inc.

GH

Guardant Health Inc.

N/A

Current Price

$84.35

Market Cap

13.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVAV
GH
Founded
1971
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
13.3B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
AVAV
GH
Price
$213.79
$84.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
20
Target Price
$329.38
$117.80
AVG Volume (30 Days)
1.9M
1.6M
Earning Date
06-09-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$147.25
$33.40
Revenue Next Year
$17.15
$28.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.88
52 Week Low
$102.25
$36.36
52 Week High
$417.86
$120.74

Technical Indicators

Market Signals
Indicator
AVAV
GH
Relative Strength Index (RSI) 38.57 27.01
Support Level $196.22 $54.39
Resistance Level $279.29 $114.53
Average True Range (ATR) 20.90 4.54
MACD -1.73 -0.84
Stochastic Oscillator 15.78 9.43

Price Performance

Historical Comparison
AVAV
GH

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: